Does ERYTHROPOIETIN Cause Therapy cessation? 26 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Therapy cessation have been filed in association with ERYTHROPOIETIN. This represents 0.3% of all adverse event reports for ERYTHROPOIETIN.
26
Reports of Therapy cessation with ERYTHROPOIETIN
0.3%
of all ERYTHROPOIETIN reports
1
Deaths
11
Hospitalizations
How Dangerous Is Therapy cessation From ERYTHROPOIETIN?
Of the 26 reports, 1 (3.8%) resulted in death, 11 (42.3%) required hospitalization.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERYTHROPOIETIN. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does ERYTHROPOIETIN Cause?
Product storage error (1,286)
Death (871)
Circumstance or information capable of leading to medication error (592)
Off label use (590)
Haemoglobin decreased (443)
Drug ineffective (370)
Anaemia (367)
Intercepted product administration error (301)
Incorrect product storage (268)
Fatigue (266)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which ERYTHROPOIETIN Alternatives Have Lower Therapy cessation Risk?
ERYTHROPOIETIN vs ESCHERICHIA COLI
ERYTHROPOIETIN vs ESCITALOPRAM
ERYTHROPOIETIN vs ESCITALOPRAM OXALATE
ERYTHROPOIETIN vs ESKETAMINE
ERYTHROPOIETIN vs ESLICARBAZEPINE